Latest Breaking News On - Ashlea kosikowski - Page 1 : vimarsana.com

Verve Therapeutics Announces Leadership Update

Troy Lister, Ph.D., to be promoted to chief scientific officer Andrew Bellinger, M.D., Ph.D., will depart the Company and serve in an advisory capacity BOSTON, May 31, 2024 Verve.

United statesFlinders universitySouth australiaTroy listerJen robinsonAndrew bellingerSekar kathiresanAshlea kosikowskiExchange commissionScripps research instituteNovartis institutes for biomedical researchVerve therapeutics incChief scientific officerChief medical officerSpero therapeuticsNovartis institutes

Verve Therapeutics Announces Leadership Update - Verve Therapeutics (NASDAQ:VERV)

Verve Therapeutics Announces Leadership Update - Verve Therapeutics (NASDAQ:VERV)
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Flinders universitySouth australiaUnited statesSekar kathiresanJen robinsonTroy listerAshlea kosikowskiAndrew bellingerExchange commissionVerve therapeutics incScripps research instituteNovartis institutes for biomedical researchChief scientific officerChief medical officerSpero therapeuticsNovartis institutes

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesJen robinsonAshlea kosikowskiVerve therapeutics incStock incentive planNasdaq listing ruleVerve therapeutics

Verve Therapeutics Announces Dosing of First Patient in Heart-2 Phase 1b Clinical Trial

Verve Therapeutics Announces Dosing of First Patient in Heart-2 Phase 1b Clinical Trial
eagletribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eagletribune.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomSekar kathiresanAshlea kosikowskiJen robinsonExchange commissionVerve therapeutics incClinical trial applicationsTrial applicationsVerve therapeuticsPrivate securities litigation reform act

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

BOSTON, May 03, 2024 Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, today.

United statesJen robinsonAshlea kosikowskiVerve therapeutics incStock incentive planNasdaq listing ruleVerve therapeutics